Universitätsklinikum Hamburg-Eppendorf
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1989-05-19
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.uke.de
PROMISE: Percutaneous peRipheral cannulatiOn for Minimally-InvaSive Heart Valve surgEry
Recruiting
- Conditions
- Mitral Valve DiseaseHeart Valve DiseasesAortic Valve DiseaseTricuspid Valve Disease
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 1000
- Registration Number
- NCT05961150
- Locations
- 🇩🇪
University Heart and Vascular Center Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study
Terminated
- Conditions
- Diabetes Mellitus, Type 2Arrhythmias, CardiacAsthmaDepressive DisorderSchizophreniaPeripheral Nervous System DiseasesHeart FailureIschemic Attack, TransientRenal InsufficiencyMyocardial Infarction
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 61
- Registration Number
- NCT05961163
- Locations
- 🇩🇪
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure
Phase 3
Not yet recruiting
- Conditions
- Ebola Vaccine
- Interventions
- Biological: ERVEBO® (rVSV∆G-ZEBOV-GP)
- First Posted Date
- 2023-07-25
- Last Posted Date
- 2024-05-13
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 70
- Registration Number
- NCT05959421
- Locations
- 🇩🇪
Bernhard Nocht Centre for Clinical Trials (BNCCT), Hamburg, Germany
🇩🇪University Hospital Frankfurt (KGU), Frankfurt, Germany
COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults
Phase 2
Withdrawn
- Conditions
- Covid19
- Interventions
- Biological: MVA-SARS-2-SOther: Placebo
- First Posted Date
- 2023-07-18
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Registration Number
- NCT05950776
Continuous Versus Bolus Administration of Norepinephrine to Treat Hypotension During Anesthetic Induction
Not Applicable
Completed
- Conditions
- Intraoperative Hypotension
- Interventions
- Procedure: Continuous norepinephrine administration
- First Posted Date
- 2023-07-11
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Kristen Thomsen
- Target Recruit Count
- 262
- Registration Number
- NCT05940649
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Proof of Concept Human Study: Dietary Intervention to Modify Intestinal Inflammation in IBD
Not Applicable
Recruiting
- Conditions
- Reduction of Intestinal Inflammatory Activity
- Interventions
- Dietary Supplement: Gluten-free diet
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 20
- Registration Number
- NCT05867537
- Locations
- 🇩🇪
Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma
Phase 1
Recruiting
- Conditions
- Multiple Myeloma in RelapseMultiple Myeloma
- Interventions
- Drug: Belantamab mafodotin, Venetoclax
- First Posted Date
- 2023-05-11
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 45
- Registration Number
- NCT05853965
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Ham, Germany
ADVOS® Versus CVVHD in Metabolic or Mixed Acidosis
Not Applicable
Recruiting
- Conditions
- Metabolic Acidosis
- Interventions
- Device: ADVOSDevice: CVVHD
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 52
- Registration Number
- NCT05842369
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Avoiding Postinduction Hypotension: the Clinical ZERO-HYPOTENSION Proof-of-concept Study
Not Applicable
Completed
- Conditions
- AnesthesiaHypotension on InductionHypotension
- Interventions
- Procedure: MonitoringProcedure: Norepinephrine preparationProcedure: Propofol administrationProcedure: Alarm adjustmentProcedure: Intervention threshold
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 120
- Registration Number
- NCT05842759
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Best End-Expiratory and Driving-pressure for Individualized Flow Controlled Ventilation in Patients With COPD
Completed
- Conditions
- AnesthesiaCOPDVentilator Lung
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 10
- Registration Number
- NCT05812365
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
© Copyright 2025. All Rights Reserved by MedPath